Oxycodoni hydrochloridum, Naloxoni hydrochloridum
| Medicinal product name | Oxsynia 5 mg/2.5 mg prolonged-release tablets |
|---|---|
| Pharmaceutical form | Prolonged-release tablet |
| Strength | 5 mg/2.5 mg |
| Information from the MAH on shortages | Not notified |
| Legal status | Prescription (Pr.I) |
| Summary of product characteristics |  23-02-2023
|
| Package leaflet | 28-12-2022
|
| ATC code | N02AA55 – Analgesics |
| Information for Marketing authorisation holders | View |
Medicinal products (12)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10 (5 mg/2,5 mg) |
PVC/Al blister | 17-0267-01 |
 Labelling text May 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14 (5 mg/2,5 mg) |
PVC/Al blister | 17-0267-02 |
Labelling text May 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (5 mg/2,5 mg) |
PVC/Al blister | 17-0267-03 |
Labelling text May 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N28 (5 mg/2,5 mg) |
PVC/Al blister | 17-0267-04 |
Labelling text May 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30 (5 mg/2,5 mg) |
PVC/Al blister | 17-0267-05 |
Labelling text May 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50 (5 mg/2,5 mg) |
PVC/Al blister | 17-0267-06 |
Labelling text May 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N56 (5 mg/2,5 mg) |
PVC/Al blister | 17-0267-07 |
Labelling text May 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (5 mg/2,5 mg) |
PVC/Al blister | 17-0267-08 |
Labelling text May 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N98 (5 mg/2,5 mg) |
PVC/Al blister | 17-0267-09 |
Labelling text May 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (5 mg/2,5 mg) |
PVC/Al blister | 17-0267-10 |
Labelling text May 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100: 10 × 10 (5 mg/2,5 mg) |
PVC/Al blister | 17-0267-11 |
Labelling text May 26, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (5 mg/2,5 mg) |
HDPE bottle | 17-0267-12 |
Labelling text May 26, 2020 Labelling text May 26, 2020 |
Registration information
| Marketing authorisation No. | 17-0267 |
|---|---|
| Date of authorisation | Dec 22, 2017 |
| Marketing authorisation holder, country | Mundipharma Gesellschaft m.b.H, Austria |
